Write in a clean editor, then format for Psychiatry and Clinical Neurosciences Reports in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Psychiatry and Clinical Neurosciences Reports is a peer-reviewed journal published by Wiley, covering Schizophrenia research and treatment, Attention Deficit Hyperactivity Disorder, COVID-19 and Mental Health.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Psychiatry and Clinical Neurosciences Reports 12 (3): 45–58.
Formats any DOI in Psychiatry and Clinical Neurosciences Reports style. No sign-up. |
| Publishes research in | Schizophrenia research and treatment Attention Deficit Hyperactivity Disorder COVID-19 and Mental Health Suicide and Self-Harm Studies Mental Health Treatment and Access |
| ISSN | 2769-2558 |
| Citation impact (2-yr) | 0.78 |
| h-index | 11 |
| i10-index | 14 |
| Total citations | 949 |
| Article processing charge | $2,500 |
| Open access | Yes |
| Top institutions publishing here | National Center of Neurology and Psychiatry |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Over the past three decades, Individual Placement and Support (IPS) has emerged as a robust evidence-based approach to helping people with severe mental illnesses, such as schizophrenia, bipolar disorder, and major depression, to obtain and succeed in competitive employment. This review addresses the history, principles, research, and future directions of IPS. It covers current evidence…
Abstract Ayahuasca is a psychedelic plant brew originating from the Amazon rainforest. It is formed from two basic components, the Banisteriopsis caapi vine and a plant containing the potent psychedelic dimethyltryptamine (DMT), usually Psychotria viridis . Here we review the history of ayahuasca and describe recent work on its pharmacology, phenomenological responses, and clinical applications.…
Pharmacogenetic (PGx) testing has emerged as a tool for predicting a person's ability to process and react to drugs. Despite the growing evidence-base, enthusiasm, and successful efforts to implement PGx testing in psychiatry, a consensus on how best to implement PGx testing into practice has not been established and numerous hurdles to widespread adoption remain…
Psychiatric disorders and related traits have a demonstrated genetic component, with heritability estimated by twin studies generally between 80% and 40%. Their pathogenesis is complex and multi-determined: environmental factors interact with a polygenic architecture, making difficult the development of models able to stratify patients or predict mental health outcomes. Despite this difficult challenge, relevant progress…
Background: There have been a limited number of case reports of clozapine-induced pneumonia. Few have reported rechallenging of clozapine after discontinuation due to the side-effect. Case Presentation: A 43-year-old man was diagnosed with schizophrenia after developing auditory hallucinations and delusions of persecution and reference. After diagnosing him with treatment-resistant schizophrenia, clozapine was started. From a…
